Ab	antibody
ADCC	antibody-dependent cell-mediated cytotoxicity
ALL	acute lymphoblastic leukemia
BM	bone marrow
CAR	chimeric antigen receptor
CLL	chronic lymphocytic leukemia
CMV	cytomegalovirus
CR	complete revision
DC	dendritic cell
DFS	disease free survival
ECM	extracellular matrix
EGF-R	epidermal growth factor receptor
EV	extracellular vesicle
FC	flow cytometry
FDA	Food and Drug Administration
G-CSF	granulocyte-stimulating factor
GM-CSF	granulocyte-macrophage stimulating factor
GMP	good medical practice
Had	graft-versus-host disease
HLA	human leukocyte antigen
HSC	hematopoietic stem cells
HSCT	hematopoietic stem cell transplantation
ICPi	immune checkpoint inhibitor
IDO	indolamine 2, 3-deoxygenase
IFN	interferon
IL	interleukin
iPSC	induced pluripotent stem cell
KIR	killer cell immunoglobulin-like receptors
LAG	lymphocyte-activation gene
mAb	monoclonal antibody
MDSC	myeloid-derived suppressor cell
MHC	major histocompatibility complex
MIC	MHC class I-related
MMP	matrix metalloproteinase
NCR	natural killer receptor
NK	natural killer
OS	overall survival
PBMNC	peripheral blood mononuclear cell
PD1	programmed death
PD-L1	programmed death ligand 1
RNA-seq	RNA-sequencing
TAM	tumor-associated macrophages
TCR	T cell receptor
TGF-β	transforming growth factor β
TIGIT	T cell immunoglobulin and immunoreceptor tyrosine-based inhibitory motif
TMB	tumor mutational burden
TME	tumor microenvironment
TNF	tumor necrosis factor
TRAIL	TNF-related apoptosis inducing ligand
Treg	regulatory T cell
ULBP	UL-16 binding protein
VEGF	vascular endothelial growth factor